Table 1

Baseline patient characteristics (N=32)

Patient characteristicsSurfactant nebulisation
(N=16)
Standard care
(N=16)
Demographic
 Gestational age at birth (weeks)29.4 (29–31.1)30.1 (27–31.1)
 Birth weight(g)1080 (930–1430)1140 (880–1360)
 Male, n (%)9 (56)7 (44)
Prenatal
 Estimated birth weight (g)1080 (880–1370)1170 (860–1360)
 Completed antenatal steroids, n (%)13 (81)10 (63)
 PPROM, n (%)6 (38)3 (19)
 Chorioamnionitis, n (%)3 (19)2 (13)
 Oligohydramnios or anhydramnios, n (%)3 (19)3 (19)
 Preeclampsia, n (%)6 (38)4 (25)
 IUGR, n (%)4 (25)4 (25)
 Delivered by CS, n (%)16 (100)14 (87)
Postnatal
 Time of cord clamping (sec)60 (41–60)60 (54–60)
 Apgar score at 5 min8 (7–8)8 (7–9)
 Umbilical artery pH7.32 (7.29–7.36)7.32 (7.27–7.32)
 Dose of SN (mg/kg)*198 (163–241)
 Start of SN (sec after birth)80 (64–88)
 Duration of SN (min)13 (9–14)
  • Unless otherwise specified, median and IQR are depicted.

  • *Dose of SN is based on the actual weight of the infant (measured after birth). There were no significant differences between groups.

  • CS, caesarean section; IUGR, intrauterine growth restriction; pCO2, partial pressure of carbon dioxide; PPROM, prolonged premature rupture of the membranes; SN, surfactant nebulisation.